Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Domingo

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Contraception|December 17, 2009
A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian womenFrancois-Xavier Mbopi-Keou, Sylvie Trottier, Rabeea F Omar, et al.
Lung|May 10, 2023
Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter StudyIgnacio Dávila, Luis Puente, Santiago Quirce, et al.
ERJ Open Research|September 27, 2023
Burden of refractory and unexplained chronic cough on patients' lives: a cohort studyLuis Puente-Maestu, Ignacio Dávila, Santiago Quirce, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 6, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthmaWilliam W Busse, Monica Kraft, Christian Domingo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 25, 2019
Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot StudyLuis A Pérez de Llano, Borja G Cosío, Christian Domingo, et al.
Allergy|July 28, 2022
Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthmaAlberto Papi, Jonathan Corren, Mario Castro, et al.
Respiratory Investigation|August 28, 2024
Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic coughChristian Domingo, Santiago Quirce, Ignacio Dávila, et al.
Allergy|July 11, 2023
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids doseIan D Pavord, Arnaud Bourdin, Alberto Papi, et al.
Contraception|October 20, 2009
A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from CameroonFrancois-Xavier Mbopi-Keou, Sylvie Trottier, Rabeea F Omar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 1, 2024
Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation StudyJorge F Maspero, Anju T Peters, Kenneth R Chapman, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Contraception|December 17, 2009
A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian womenFrancois-Xavier Mbopi-Keou, Sylvie Trottier, Rabeea F Omar, et al.
Lung|May 10, 2023
Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter StudyIgnacio Dávila, Luis Puente, Santiago Quirce, et al.
ERJ Open Research|September 27, 2023
Burden of refractory and unexplained chronic cough on patients' lives: a cohort studyLuis Puente-Maestu, Ignacio Dávila, Santiago Quirce, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 6, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthmaWilliam W Busse, Monica Kraft, Christian Domingo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 25, 2019
Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot StudyLuis A Pérez de Llano, Borja G Cosío, Christian Domingo, et al.
Allergy|July 28, 2022
Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthmaAlberto Papi, Jonathan Corren, Mario Castro, et al.
Respiratory Investigation|August 28, 2024
Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic coughChristian Domingo, Santiago Quirce, Ignacio Dávila, et al.
Allergy|July 11, 2023
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids doseIan D Pavord, Arnaud Bourdin, Alberto Papi, et al.
Contraception|October 20, 2009
A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from CameroonFrancois-Xavier Mbopi-Keou, Sylvie Trottier, Rabeea F Omar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 1, 2024
Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma: TRAVERSE Continuation StudyJorge F Maspero, Anju T Peters, Kenneth R Chapman, et al.
Pageof 11